Singapore Institute for Clinical Sciences (SICS)

Chemicals in everyday products may impact babies’ metabolic health, potentially leading to increased belly fat at birth.

Smartwatch data points to a connection between physical activity and prolonged COVID-19 symptoms among healthcare workers.

Through innovative technologies and deep biological insights, A*STAR research institutes and ecosystem partners aim to enhance the healthspan of Asia’s ageing populations.

The term ‘postpartum depression’ may be misleading, as researchers have discover maternal depressive symptoms often begin during pregnancy.

Despite an increased calorie intake, the consumption of unsaturated fats from Asian-based oil blends did not lead to significant changes in total body fat among Asian participants.

The A*STAR winners of the 2021 President’s Science and Technology Awards and Young Scientist Award are living proof of the importance of mentorship in creating science that gives back to the community.

New data suggest that metformin administered to pregnant mothers may have unintended effects on the fetus, prompting the need for further assessment of the drug’s risk-benefit ratio.

From the public sector to innovative startups and industry giants, A*STAR scholars are blazing the trail across Singapore’s research ecosystem.

From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.

Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.

Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.

Understanding the impact of antibiotics on both infants and adults could help restore the delicate balance of the gut microbiome.